REFERENCES
- Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163(5):1256–1276. [PUBMED], [INFOTRIEVE], [CSA]
- Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR, Surveill Summ 2002; 51(6):1–16. [CSA]
- Murray C J, Lopez A D. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 1997; 349(9064):1498–1504. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93(3):391–398.
- Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1(8222):681–686. [CROSSREF]
- Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood D E. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348(21):2059–2073. [PUBMED], [INFOTRIEVE], [CROSSREF]
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 Pt 2):S77–S121. [CSA]
- Siafakas N M, Vermeire P, Pride N B, Paoletti P, Gibson J, Howard P, Yernault J C, Decramer M, Higenbottam T, Postma D S, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8(8):1398–1420. [PUBMED], [INFOTRIEVE], [CROSSREF]
- The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(suppl 5):S1–S28.
- Fabbri L M, Hurd S S. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003; 22(1):1–2. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rennard S I. Looking at the patient—approaching the problem of COPD. N Engl J Med 2004; 350(10):965–966. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Snider G L. Nosology for our day: its application to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(5):678–683. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fabbri L M, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(3):418–424. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ries A L, Kaplan R M, Myers R, Prewitt L M. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003; 167(6):880–888. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ribera F, N'Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(6):873–879. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sutherland E R, Cherniack R M. Management of chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2689–2697. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sin D D, McAlister F A, Man S F, Anthonisen N R. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290(17):2301–2312. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Man S F, McAlister F A, Anthonisen N R, Sin D D. Contemporary management of chronic obstructive pulmonary disease: clinical applications. JAMA 2003; 290(17):2313–2316. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniack R M, Rogers R M, Sciurba F C, Coxson H O, Pare P D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2645–2653. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Barnes P J. Small airways in COPD. N Engl J Med 2004; 350(26):2635–2637. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Schunemann H J, Dorn J, Grant B J, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118(3):656–664. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bang K M, Gergen P J, Kramer R, Cohen B. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993; 103(2):536–540. [PUBMED], [INFOTRIEVE]
- Hole D J, Watt G C, Davey-Smith G, Hart C L, Gillis C R, Hawthorne V M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. Br Med J 1996; 313(7059):711–715; discussion 715–716.
- Friedman G D, Klatsky A L, Siegelaub A B. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294(20):1071–1075. [PUBMED], [INFOTRIEVE]
- Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106(20):2555–2560. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sin D D, Man S F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11):1514–1519., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ionescu A A, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J, Suppl 2003; 46:64s–75s.
- Jagoe R T, Engelen M P. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J, Suppl 2003; 46:52s–63s.
- Liesker J J, Postma D S, Beukema R J, ten Hacken N H, van der Molen T, Riemersma R A, van Zomeren E H, Kerstjens H A. Cognitive performance in patients with COPD. Respir Med 2004; 98(4):351–356. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Casaburi R, Bhasin S, Cosentino L, Porszasz J, Somfay A, Lewis M I, Fournier M, Storer T W. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 30(8):870–878. [CROSSREF]
- Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 58(10):832–834. [PUBMED], [INFOTRIEVE], [CROSSREF]
- De Boer W I. Cytokines and therapy in COPD: a promising combination? Chest 2002; 121(suppl 5):209S–218S. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Turato G, Di Stefano A, Maestrelli P, Mapp C E, Ruggieri M P, Roggeri A, Fabbri L M, Saetta M. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995; 152(4 Pt 1):1262–1267. [PUBMED], [INFOTRIEVE], [CSA]
- Rutgers S R, Postma D S, ten Hacken N H, Kauffman H F, van Der Mark T W, Koeter G H, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55(1):12–18. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Retamales I, Elliott W M, Meshi B, Coxson H O, Pare P D, Sciurba F C, Rogers R M, Hayashi S, Hogg J C. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164(3):469–473. [PUBMED], [INFOTRIEVE], [CSA]
- Domagala-Kulawik J, Maskey-Warzechowska M, Kraszewska I, Chazan R. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 2003; 123(4):1054–1059. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Croxton T L, Weinmann G G, Senior R M, Wise R A, Crapo J D, Buist A S. Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med 2003; 167(8):1142–1149. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diaz P T, Clanton T L, Pacht E R. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992; 116(2):124–128. [PUBMED], [INFOTRIEVE], [CSA]
- Diaz P T, King M A, Pacht E R, Wewers M D, Gadek J E, Neal D, Nagaraja H N, Drake J, Clanton T L. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999; 160(1):272–277. [PUBMED], [INFOTRIEVE], [CSA]
- Diaz P T, King M A, Pacht E R, Wewers M D, Gadek J E, Nagaraja H N, Drake J, Clanton T L. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132(5):369–372. [PUBMED], [INFOTRIEVE], [CSA]
- Voelkel N F, MacNee W. Chronic Obstructive Lung Diseases. Toronto, Decker 2002.
- Hogg J C. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001; 164(10 Pt 2):S71–S75. [PUBMED], [INFOTRIEVE], [CSA]
- Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies W A, Hogg J C. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146(1):177–184. [PUBMED], [INFOTRIEVE], [CSA]
- Vitalis T Z, Kern I, Croome A, Behzad H, Hayashi S, Hogg J C. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur Respir J 1998; 11(3):664–669. [PUBMED], [INFOTRIEVE]
- Meshi B, Vitalis T Z, Ionescu D, Elliott W M, Liu C, Wang X D, Hayashi S, Hogg J C. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002; 26(1):52–57. [PUBMED], [INFOTRIEVE], [CSA]
- Ogawa E, Elliott W M, Hughes F, Eichholtz T J, Hogg J C, Hayashi S. Latent adenoviral infection induces production of growth factors relevant to airway remodeling in COPD. Am J Physiol, Lung Cell Mol Physiol 2004; 286(1):L189–L197. [CSA], [CROSSREF]
- Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343(26):1902–1909. [CSA], [CROSSREF]
- Morris A, Sciurba F C, Lebedeva I P, Githaiga A, Elliott W M, Hogg J C, Huang L, Norris K A. Association of chronic obstructive pulmonary disease severity and pneumocystis colonization. Am J Respir Crit Care Med 2004; 170(4):408–413. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Morris A M, Huang L, Bacchetti P, Turner J, Hopewell P C, Wallace J M, Kvale P A, Rosen M J, Glassroth J, Reichman L B, Stansell J D, The Pulmonary Complications of HIV Infection Study Group. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. Am J Respir Crit Care Med 2000; 162(2 Pt 1):612–616. [PUBMED], [INFOTRIEVE], [CSA]
- Innocenti F, Fabbri A, Anichini R, Tuci S, Pettina G, Vannucci F, De Giorgio L A, Seghieri G. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract 1994; 25(3):161–168. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Primhak R A, Whincup G, Tsanakas J N, Milner R D. Reduced vital capacity in insulin-dependent diabetes. Diabetes 1987; 36(3):324–326. [PUBMED], [INFOTRIEVE]
- Maccioni F J, Colebatch H J. Lung volume and distensibility in insulin-dependent diabetes mellitus. Am Rev Respir Dis 1991; 143(6):1253–1256. [PUBMED], [INFOTRIEVE]
- Sandler M, Bunn A E, Stewart R I. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987; 135(1):223–229. [PUBMED], [INFOTRIEVE]
- Walter R E, Beiser A, Givelber R J, O'Connor G T, Gottlieb D J. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003; 167(6):911–916. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gumieniczek A, Hopkala H, Wojtowicz Z, Wysocka M. Changes in antioxidant status of lung tissue in experimental diabetes in rabbits. Clin Biochem 2002; 35(2):147–149. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gardai S J, Xiao Y Q, Dickinson M, Nick J A, Voelker D R, Greene K E, Henson P M. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115(1):13–23. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Vandivier R W, Fadok V A, Hoffmann P R, Bratton D L, Penvari C, Brown K K, Brain J D, Accurso F J, Henson P M. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002; 109(5):661–670. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guo X, Lin H M, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18(3):482–490. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yang I A, Seeney S L, Wolter J M, Anders E M, McCormack J G, Tunnicliffe A M, Rabnott G C, Shaw J G, Dent A G, Kim S T, Zimmerman P V, Fong K M. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes Immun 2003; 4(4):269–274. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ogden C A, deCathelineau A, Hoffmann P R, Bratton D, Ghebrehiwet B, Fadok V A, Henson P M. C1q and mannose binding lectin engagement of cell surface calreticulin and cd91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194(6):781–796. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hodge S, Hodge G, Scicchitano R, Reynolds P N, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003; 81(4):289–296., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhao M Q, Stoler M H, Liu A N, Wei B, Soguero C, Hahn Y S, Enelow R I. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition. J Clin Invest 2000; 106(6):R49–R58. [PUBMED], [INFOTRIEVE], [CSA]
- Barnes P J, Ito K, Adcock I M. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 2004; 363(9410):731–733. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ito K, Lim S, Caramori G, Chung K F, Barnes P J, Adcock I M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15(6):1110–1112. [PUBMED], [INFOTRIEVE], [CSA]
- Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125(2):626–632. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kasahara Y, Tuder R M, Cool C D, Lynch D A, Flores S C, Voelkel N F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001; 163(3 Pt 1):737–744. [PUBMED], [INFOTRIEVE], [CSA]
- Kasahara Y, Tuder R M, Taraseviciene-Stewart L, Le Cras T D, Abman S, Hirth P K, Waltenberger J, Voelkel N F. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106(11):1311–1319. [PUBMED], [INFOTRIEVE], [CSA]
- Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003; 28(5):555–562. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Suratt B T, Cool C D, Serls A E, Chen L, Varella-Garcia M, Shpall E J, Brown K K, Worthen G S. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168(3):318–322. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Raeside D A, Brown A, Patel K R, Welsh D, Peacock A J. Ambulatory pulmonary artery pressure monitoring during sleep and exercise in normal individuals and patients with COPD. Thorax 2002; 57(12):1050–1053. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Weitzenblum E, Chaouat A. Sleep and chronic obstructive pulmonary disease. Sleep Med Rev 2004; 8(4):281–294. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Landbo C, Prescott E, Lange P, Vestbo J, Almdal T P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(6):1856–1861. [PUBMED], [INFOTRIEVE], [CSA]
- Gerardi D A, Lovett L, Benoit-Connors M L, Reardon J Z, ZuWallack R L. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J 1996; 9(3):431–435. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Celli B R, Cote C G, Marin J M, Casanova C, Montes de Oca M, Mendez R A, Pinto Plata V, Cabral H J. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005–1012. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ussetti P, Laporta R. Predicting outcomes in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(22):2308–2310 author reply 2308–2310. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167(4):544–549. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Barbera J A, Peinado V I, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003; 21(5):892–905. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Paredi P, Kharitonov S A, Barnes P J. Analysis of expired air for oxidation products. Am J Respir Crit Care Med 2002; 166(12 Pt 2):S31–S37. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mannino D M, Ford E S, Redd S C. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114(9):758–762. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gan W Q, Man S F, Senthilselvan A, Sin D D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59(7):574–580. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dentener M A, Creutzberg E C, Schols A M, Mantovani A, van't Veer C, Buurman W A, Wouters E F. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 2001; 56(9):721–726. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sin D D, Lacy P, York E, Man S F. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170(7):760–765. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sullivan S D, Ramsey S D, Lee T A. The economic burden of COPD. Chest 2000; 117(2 Suppl):5S–9S. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gerrits C M, Herings R M, Leufkens H G, Lammers J W. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 21(5):795–798. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Aaron S D, Vandemheen K L, Hebert P, Dales R, Stiell I G, Ahuja J, Dickinson G, Brison R, Rowe B H, Dreyer J, Yetisir E, Cass D, Wells G. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348(26):2618–2625. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003; 168(1):49–53. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- MacIntyre N R. Chronic obstructive pulmonary disease: emerging medical therapies. Respir Care 2004; 49(1):64–69 discussion 69–71. [PUBMED], [INFOTRIEVE], [CSA]
- Massaro G D, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997; 3(6):675–677. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Massaro D, Massaro G D. Retinoids, alveolus formation, and alveolar deficiency: clinical implications. Am J Respir Cell Mol Biol 2003; 28(3):271–274. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mao J T, Goldin J G, Dermand J, Ibrahim G, Brown M S, Emerick A, McNitt-Gray M F, Gjertson D W, Estrada F, Tashkin D P, Roth M D. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med 2002; 165(5):718–723. [PUBMED], [INFOTRIEVE], [CSA]
- Tuder R M, Zhen L, Cho C Y, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel N F, Flores S C. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003; 29(1):88–97. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Massaro G D, Radaeva S, Clerch L B, Massaro D. Lung alveoli: endogenous programmed destruction and regeneration. Am J Physiol, Lung Cell Mol Physiol 2002; 283(2):L305–L309. [CSA]
- Massaro D, Massaro G D, Baras A, Hoffman E P, Clerch L B. Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression. Am J Physiol, Lung Cell Mol Physiol 2004; 286(5):L896–L906. [CSA], [CROSSREF]
- Winick M. Hunger disease. Studies by the Jewish Physicians in the Warsaw Ghetto. New York: Wiley, 1979.
- Cook V J, Coxson H O, Mason A G, Bai T R. Bullae, bronchiectasis and nutritional emphysema in severe anorexia nervosa. Can Respir J 2001; 8(5):361–365. [PUBMED], [INFOTRIEVE], [CSA]
- Crow S, Praus B, Thuras P. Mortality from eating disorders—a 5- to 10-year record linkage study. Int J Eat Disord 1999; 26(1):97–101. [PUBMED], [INFOTRIEVE], [CSA]
- Morris D G, Huang X, Kaminski N, Wang Y, Shapiro S D, Dolganov G, Glick A, Sheppard D. Loss of integrin α(v)β6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 2003; 422(6928):169–173. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Choe K H, Taraseviciene-Stewart L, Scerbavicius R, Gera L, Tuder R M, Voelkel N F. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med 2003; 167(11):1516–1521. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]